HOME PHOTOTHERAPY UNITS
Panosol II home UVB light panel
Scalp Psoriasis Treatment 
Hand/Foot II
Lamps, Meters, & Eye Protection
REQUEST A BROCHURE
PHOTOTHERAPY AT HOME
Why Home Phototherapy?
What Does Home Therapy Cost?
How to Get Started
Equipment Selection Guide 
Insurance Guide 
REGISTER AND SAVE
INSURANCE FORMS
Insurance Reimbursement
Sales Agreement 
Assignment of Benefits
Insurance Claim Form
Letter of Medical Necessity
demystifying the lights
Narrow band UVB Lights
Narrowband UVB and UV lamps
PUVA: Psoralen plus UVA
Blue Lights for Acne
skin conditions & uv light
Psoriasis Information from NPF
Psoriasis and Phototherapy
Vitiligo and Phototherapy
Eczema and Phototherapy
Acne and Blue Lights
Tell Us Your Phototherapy Story
facts about PHOTOTHERAPY
How UV Phototherapy Works
Benefits of Ultraviolet Light
UV Light Treatment Regimen
How Safe is Phototherapy 
How Effective is Phototherapy 
Home Phototherapy Affordability
Insurance Covers Home Units
Phototherapy vs the Medications
Biologics May Pose Cancer Risk
NEWS
Cost of Home UVB Phototherapy
ABOUT NATIONAL BIOLOGICAL
Hear From Our Customers
On-Site Manufacturing Facility 
Resources for Patients 
Patient Phototherapy FAQ
About Us
NEED HELP?
Site Map
CONTACT US
800-338-5045

 


PATIENTS     PHYSICIANS     THIRD PARTY PAYERS     HOME    

Home Phototherapy IS an Economical Treatment

   Home phototherapy is generally less costly for treatment of chronic conditions. 
   Home phototherapy reduces time and cost of regular office visits to the physician. 
   Insurance companies save too, so they generally reimburse equipment costs. 
   Read our insurance reimbursement guide for more information.

Below are some research studies showing cost-effectiveness of phototherapy and home phototherapy.

#1 Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety, and cost. Feldman SR; Garton R; Averett W; Balkrishnan R; and Vallee J. Expert Opinion On Pharmacotherapy [Expert Opin Pharmacother] 2003 Sep; Vol. 4 (9), pp. 1525-33.
ABSTRACT: Psoriasis is a common, unpredictable, chronic immune-mediated disease characterised by skin lesions and frequently associated with arthritis. Although rarely fatal, psoriasis has a tremendous impact on a patients' quality of life. Traditional therapies for severe psoriasis include phototherapy, methotrexate, oral retinoids and cyclosporin. New biological agents add to the treatment options for psoriasis; however, they raise the already considerable cost of managing the disease. In considering efficacy, safety and cost-effectiveness, ultraviolet Type B (UVB) phototherapy appears to be the best first-line agent for the control of psoriasis. Methotrexate, psoralen plus UVA, alefacept, etanercept and infliximab are appropriate second-line agents, the choice of which requires considerable patient input and physician judgement. Developing rational, effective and acceptable strategies to manage psoriasis treatments would encourage cost-effective psoriasis management.
#2 Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Samson Yashar S. Photodermatology, Photoimmunology & Photomedicine [Photodermatol Photoimmunol Photomed], 2003 Aug; Vol. 19 (4), pp. 164-8; PMID: 12925186

BACKGROUND: Narrow-band ultraviolet B (NB-UVB) therapy has been used successfully for the treatment of inflammatory and pigmentary skin disorders including atopic dermatitis, psoriasis, mycosis fungoides, polymorphous light eruption, and vitiligo. METHODS: This is a retrospective review of the treatment outcomes of 117 consecutive patients with vitiligo, pruritus, and other inflammatory dermatoses, excluding those with psoriasis and CTCL, who were treated with NB-UVB between 1998 and 2001 at our institution. RESULTS: Approximately 80% of all patients showed improvement in their condition. NB-UVB phototherapy was well tolerated, with no serious adverse effects. In patients with vitiligo, 6.4% had an abnormal thyroid-stimulating hormone level and 6.5% had anemia.

CONCLUSION: NB-UVB may be considered as a viable therapeutic option in the treatment of vitiligo, pruritus, and other inflammatory dermatoses. Long-term adverse effects and cost-benefit analysis of NB-UVB therapy compared to other treatment modalities remain to be determined.

 

#3 At-Home UVB Therapy vs. Systemic Therapies:  Calculating the Lifetime Cost of Care Compared to Other Therapies.  Skin and Aging, CB Yelverton, AS Kulkarni, R Balkrishnan, SR Feldman.  1096-0120, Vol 13, Issue 7_2005, July 2005, Pages 50-52
At-home treatments with ultraviolet type-B (UVB) phototherapy can offer a convenient, cost-effective and efficacious choice for treatmentof your patients’ psoriasis, researchers noted in a poster they presented at [the 2005] American Academy of Dermatology.  After gathering and analyzing the data, researchers concluded that phototherapy continues to be “an effective and relatively inexpensive option for many patients.” Home UVB therapy was the least expensive, costing about $7,100 for a 30-year course of treatment. Some of the drug treatments studied cost up to $300,000 over the same time frame.
Read complete article
 
 

Home UVB Phototherapy Equipment: Panosol II - Dermalight 80 - Foldalite III  - Hand/Foot II
Home UVA Phototherapy Treatment
: Panosol II - Handisol - Hand/Foot II

Popular Psoriasis Home Phototherapy Home Units: Panasol/Panosol II - Dermalite/Dermalight80
Treatment guides: Phototherapy UV psoriasis light treatments - Phototherapy Vitiligo treatment
        narrowband UVB - How phototherapy can help